Abstract
Each year 600,000 individuals are diagnosed with head and neck squamous cell carcinoma (HNSCC), the eigth most common type of cancer worldwide, with a 5-year survival rate below 50% in advanced cases. Treatment of HNSCC had no major progress in the past 4 decades, with surgical resection with/without radiotherapy or radio-chemotherapy still the most frequent treatment approaches, which is…